Soleno Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOLENO THERAP
SOLENO THERAP has one approved drug.
There are six US patents protecting SOLENO THERAP drugs.
Summary for Soleno Therap
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Soleno Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Soleno Therap | VYKAT XR | diazoxide choline | TABLET, EXTENDED RELEASE;ORAL | 216665-002 | Mar 26, 2025 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Soleno Therap | VYKAT XR | diazoxide choline | TABLET, EXTENDED RELEASE;ORAL | 216665-002 | Mar 26, 2025 | RX | Yes | No | 7,572,789 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Soleno Therap | VYKAT XR | diazoxide choline | TABLET, EXTENDED RELEASE;ORAL | 216665-001 | Mar 26, 2025 | RX | Yes | No | 7,799,777 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Soleno Therap | VYKAT XR | diazoxide choline | TABLET, EXTENDED RELEASE;ORAL | 216665-003 | Mar 26, 2025 | RX | Yes | Yes | 7,799,777 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Soleno Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1214945 | ⤷ Start Trial |
| European Patent Office | 2404605 | ⤷ Start Trial |
| South Korea | 102598666 | ⤷ Start Trial |
| New Zealand | 768958 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
